Quantitating Autism Risk in Father’s Sperm
Spontaneous mutations in paternal sperm are linked to autism spectrum disorder; researchers have developed way to quantify those mutations and assess chances the mutations will cause disease.
Related Articles
Repetitive HIV Immunization Can Elicit Anti-Immune Complex Antibodies
Repetitive HIV vaccinations can lead the body to produce antibodies targeting the immune complexes already bound to the virus.
2025 Trends: Multiomics
Experts in multiomics share their predictions of the potential and needs of the field in the near future.
Polyintelligence
The emergence of polyintelligence will give us the chance to spark a modern technological renaissance to tackle our greatest challenges.
Protective Immune Cells’ Function Altered by Cigarette Smoke Components
Researchers used computer modeling to predict which components of cigarette smoke might be recognized by antigen-presenting molecule MR1.
Repetitive HIV Immunization Can Elicit Anti-Immune Complex Antibodies
Repetitive HIV vaccinations can lead the body to produce antibodies targeting the immune complexes already bound to the virus.
Major Trends in Cell and Gene Therapy
Past advances and new technologies will continue to bring genomic medicine from concept to reality.
Genetic Reanalysis Provides New Rare Disease Diagnoses
Study highlights use of techniques such as long-read genome sequencing, optical genome mapping, and RNA sequencing for rare disease diagnosis.
Généthon, Eukarÿs Partnership Aims to Lower Manufacturing Costs for Gene Therapies
The partners will adapt Eukarÿs’ C3P3 engineered enzyme tech to work with adeno-associated virus vectors to boost biomanufacturing yields.
Y Chromosome Genes That Impact Sperm Development and Fertility Uncovered in Mice
Researchers say study represents a resource that could also help to dissect Y-gene functions in other tissues.
StockWatch: Up-to-$500B AI Venture Sparks Investor Interest, and Questions
Stargate CEOs cite project’s promise of enabling cancer vaccines, though Musk joins critics in questioning partners’ financial strength and wisdom of the joint venture.